Advanced search

Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease

(2010) INFLAMMATORY BOWEL DISEASES. 16(1). p.58-67
Author
Organization
Abstract
Background: An increased risk of Crohn's disease (CD) has been reported consistently in first-degree relatives of patients. Our aim was to test whether a combination of CD-associated genes involved in innate immunity and/or antibody responses to microbial antigens may be valuable in identifying healthy relatives at risk. Methods: We investigated 86 families from Beloium and northern France, 45 with at least 3 first-degree relatives with CD, 24 with a single case, and 17 control families without inflammatory bowel disease (IBD). The cohort consisted of 186 CD patients, 290 healthy relatives, and 142 controls (total 618). Genetic (NOD2, NODI, TLR4, CARD8) and serologic markers (ASCA, ACMA, ALCA, ACCA, A Sigma MA, OmpC, CBir1, I2) were determined in all subjects. All Belgian families were prospectively followed up for 54 months. Results: In multiple-affected families, an increment of affected first-degree relatives and of positive antibodies were additive risks factors for CD (P < 0.0001), independent of NOD2 mutations. When comparing subjects from multiple-affected families, having 3 additional first-degree relatives with CD and 1 additional positive antibody increased the odds for CD to 9.19 (95% confidence interval [CI]: 4.07-20.80). After a follow-up of 54 months among all Belgian families, a total of 4 new diagnoses of IBD were confirmed in the multiple-affected families only, resulting in a 57-fold increase in incidence within multiple-affected families compared to the known incidence of IBD in our region. Conclusions: We found an additive risk increment for CD in subjects from multicase families per additional affected relative and per additional positive antibody, independent of NOD2. Furthermore, a very high disease incidence was observed in these multiple-affected families.
Keywords
INFLAMMATORY-BOWEL-DISEASE, ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES, CLINICAL CHARACTERISTICS, AGE, ANTICIPATION, CONCORDANCE, PREVALENCE, DIAGNOSIS, BELGIUM, COUPLES, antimicrobial antibodies, disease prediction, familial aggregation, IBD, incidence, NOD2

Citation

Please use this url to cite or link to this publication:

Chicago
Joossens, Marie, Kristel Van Steen, Julien Branche, Boualem Sendid, Paul Rutgeerts, Francis Vasseur, Daniel Poulain, et al. 2010. “Familial Aggregation and Antimicrobial Response Dose-dependently Affect the Risk for Crohn’s Disease.” Inflammatory Bowel Diseases 16 (1): 58–67.
APA
Joossens, M., Van Steen, K., Branche, J., Sendid, B., Rutgeerts, P., Vasseur, F., Poulain, D., et al. (2010). Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn’s disease. INFLAMMATORY BOWEL DISEASES, 16(1), 58–67.
Vancouver
1.
Joossens M, Van Steen K, Branche J, Sendid B, Rutgeerts P, Vasseur F, et al. Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn’s disease. INFLAMMATORY BOWEL DISEASES. 2010;16(1):58–67.
MLA
Joossens, Marie, Kristel Van Steen, Julien Branche, et al. “Familial Aggregation and Antimicrobial Response Dose-dependently Affect the Risk for Crohn’s Disease.” INFLAMMATORY BOWEL DISEASES 16.1 (2010): 58–67. Print.
@article{8540948,
  abstract     = {Background: An increased risk of Crohn's disease (CD) has been reported consistently in first-degree relatives of patients. Our aim was to test whether a combination of CD-associated genes involved in innate immunity and/or antibody responses to microbial antigens may be valuable in identifying healthy relatives at risk. 
Methods: We investigated 86 families from Beloium and northern France, 45 with at least 3 first-degree relatives with CD, 24 with a single case, and 17 control families without inflammatory bowel disease (IBD). The cohort consisted of 186 CD patients, 290 healthy relatives, and 142 controls (total 618). Genetic (NOD2, NODI, TLR4, CARD8) and serologic markers (ASCA, ACMA, ALCA, ACCA, A Sigma MA, OmpC, CBir1, I2) were determined in all subjects. All Belgian families were prospectively followed up for 54 months. 
Results: In multiple-affected families, an increment of affected first-degree relatives and of positive antibodies were additive risks factors for CD (P {\textlangle} 0.0001), independent of NOD2 mutations. When comparing subjects from multiple-affected families, having 3 additional first-degree relatives with CD and 1 additional positive antibody increased the odds for CD to 9.19 (95\% confidence interval [CI]: 4.07-20.80). After a follow-up of 54 months among all Belgian families, a total of 4 new diagnoses of IBD were confirmed in the multiple-affected families only, resulting in a 57-fold increase in incidence within multiple-affected families compared to the known incidence of IBD in our region. 
Conclusions: We found an additive risk increment for CD in subjects from multicase families per additional affected relative and per additional positive antibody, independent of NOD2. Furthermore, a very high disease incidence was observed in these multiple-affected families.},
  author       = {Joossens, Marie and Van Steen, Kristel and Branche, Julien and Sendid, Boualem and Rutgeerts, Paul and Vasseur, Francis and Poulain, Daniel and Broly, Franck and Colombel, Jean-Frederic and Vermeire, Severine and Chamaillard, Mathias},
  issn         = {1078-0998},
  journal      = {INFLAMMATORY BOWEL DISEASES},
  keyword      = {INFLAMMATORY-BOWEL-DISEASE,ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES,CLINICAL CHARACTERISTICS,AGE,ANTICIPATION,CONCORDANCE,PREVALENCE,DIAGNOSIS,BELGIUM,COUPLES,antimicrobial antibodies,disease prediction,familial aggregation,IBD,incidence,NOD2},
  language     = {eng},
  number       = {1},
  pages        = {58--67},
  title        = {Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease},
  url          = {http://dx.doi.org/10.1002/ibd.20985},
  volume       = {16},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: